Comparison of the anti-arrhythmic action and beta-blocking potency of LB 46 and (--)-propranolol.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000627:therapeutic use*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D001665:Binding Sites; D004285:Dogs; D005260:Female; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D010042:Ouabain / Q000494:pharmacology; D011433:Propranolol / Q000627:therapeutic use*; D011955:Receptors, Drug; D013565:Sympatholytics / Q000494:pharmacology; D013610:Tachycardia / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D000889:Anti-Arrhythmia Agents; D007211:Indoles; D011955:Receptors, Drug; D013565:Sympatholytics; D010042:Ouabain; D011433:Propranolol